Express Scripts Holding Company (NASDAQ:ESRX) Director Woodrow A. Myers, Jr. sold 3,900 shares of the stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $63.93, for a total value of $249,327.00. Following the sale, the director now directly owns 11,500 shares in the company, valued at $735,195. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Express Scripts Holding Company (NASDAQ:ESRX) opened at 62.64 on Wednesday. The stock has a market capitalization of $36.18 billion, a price-to-earnings ratio of 10.87 and a beta of 0.88. The company has a 50-day moving average of $61.89 and a 200-day moving average of $63.36. Express Scripts Holding Company has a 52 week low of $57.80 and a 52 week high of $77.50.

Express Scripts Holding (NASDAQ:ESRX) last issued its earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The company had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. During the same period in the prior year, the business posted $1.57 earnings per share. The firm’s revenue for the quarter was up .5% compared to the same quarter last year. Analysts anticipate that Express Scripts Holding Company will post $6.99 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This article was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and republished in violation of U.S. and international copyright and trademark law. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/09/13/express-scripts-holding-company-esrx-director-woodrow-a-myers-jr-sells-3900-shares.html.

Several equities research analysts have weighed in on the company. Robert W. Baird reaffirmed a “hold” rating and set a $56.00 price target on shares of Express Scripts Holding in a research report on Friday, September 1st. Morgan Stanley raised their target price on Express Scripts Holding from $52.00 to $57.00 and gave the company an “underweight” rating in a research report on Thursday, August 10th. Needham & Company LLC assumed coverage on Express Scripts Holding in a research report on Friday, July 21st. They set a “hold” rating on the stock. ValuEngine cut Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, BidaskClub cut Express Scripts Holding from a “sell” rating to a “strong sell” rating in a research report on Friday, August 4th. Four analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $70.24.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. grew its position in shares of Express Scripts Holding by 1.6% in the first quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock valued at $2,652,964,000 after purchasing an additional 649,400 shares during the last quarter. Dodge & Cox grew its position in shares of Express Scripts Holding by 25.7% in the second quarter. Dodge & Cox now owns 36,188,517 shares of the company’s stock valued at $2,310,275,000 after purchasing an additional 7,388,021 shares during the last quarter. State Street Corp grew its position in shares of Express Scripts Holding by 1.1% in the first quarter. State Street Corp now owns 27,060,709 shares of the company’s stock valued at $1,783,569,000 after purchasing an additional 298,341 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC grew its position in shares of Express Scripts Holding by 4.2% in the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock valued at $1,160,862,000 after purchasing an additional 704,218 shares during the last quarter. Finally, Macquarie Group Ltd. grew its position in shares of Express Scripts Holding by 8.4% in the second quarter. Macquarie Group Ltd. now owns 11,880,919 shares of the company’s stock valued at $758,480,000 after purchasing an additional 922,406 shares during the last quarter. Institutional investors own 88.71% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.